PAREXEL Consulting has appointed Toby Silverman (MD) and Keith Watson (PhD) as principal consultants. For 20 years, Dr Silverman served at the US Food and Drug Administration's Center for Biologics Evaluation and Research; he was most recently senior advisor in the agency’s Office of Blood Research and Review...
Scrip Regulatory Affairs
21 June 2010
Maureen Kenny
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US PDUFA V deal adds 60-day cushion for new drug, biologic reviews
- Restrictions on business activities of ex EMA head needed to "assure public confidence" in agency
- Restrictions on business activities of ex EMA head needed to "assure public confidence" in agency - update
- EMA moves to fine-tune biosimilars regulation
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
